Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...

Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...

EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...

In a report released on February 14, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...

These three premier ASX healthcare stocks just reported half-yearly earnings – and each saw its share price dip…So, is now the time to buy?

He said that hedge fund ownership of potential deregulation beneficiaries, stocks with small business exposure, and domestic ...

Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the ...

UBS strategist Joni Teves is breaking her own rules — so are strategists at Goldman Sachs.

Goldman Sachs analyst Matt Greene maintained a Buy rating on Glencore (GLEN – Research Report) today and set a price target of £5.00. The ...

Strategists at Goldman Sachs Group Inc. expect a blistering rally in Chinese equities to continue, as the emergence of DeepSeek sparks optimism over the country’s technological advancements.